Stocks On the Move: Celldex Therapeutics, Inc., Coupons.com Inc, and Nu Skin Enterprises, Inc.

CLDX, COUP, and NUS are moving sharply in Wednesday's trading

by Alex Eppstein

Published on Nov 5, 2014 at 11:09 AM
Updated on Apr 20, 2015 at 5:10 PM

Around midday, three of the top market movers are biopharmaceutical name Celldex Therapeutics, Inc. (NASDAQ:CLDX), digital promotion platform Coupons.com Inc (NYSE:COUP), and anti-aging products marketer Nu Skin Enterprises, Inc. (NYSE:NUS). Here's a quick roundup of how CLDX, COUP, and NUS are performing on the charts so far.

  • CLDX has tumbled 11.5% this morning, despite a slimmer-than-expected third-quarter loss and revenue beat. At last check, the shares are perched at $14.67, bringing their year-to-date loss beyond 39%. In options land, traders have been buying to open puts over calls at a near-extreme rate in recent weeks. Specifically, during the past 10 days, Celldex Therapeutics, Inc. has racked up a put/call volume ratio of 1.24 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). Not only does this number reveal that long puts outstrip long calls, it also ranks just 1 percentage point from a 12-month high.

  • COUP has tacked on 24.5% to trade at $15.49, after exceeding the Street's expectations in the earnings confessional. In fact, since hitting a record low of $11.61 in late August, the Wall Street rookie has rallied more than 33%. Nevertheless, just one brokerage firm is currently following Coupons.com Inc., and 7.4% of the equity's float is sold short, representing more than six sessions' worth of pent-up buying demand, at average daily trading levels. Should the shares maintain their recent positive momentum, a round of bullish initiations and/or a short-covering rally could be in the cards.

  • Finally, NUS plunged to an annual low of $39.46 earlier, and was last seen 15% south of breakeven at $42.84. Impacting the security today was a reduced current-quarter forecast, which overshadowed a third-quarter earnings and revenue beat. Year-to-date, Nu Skin Enterprises, Inc. is now sitting on a brow-raising deficit of 69%. Elsewhere, at the ISE, CBOE, and PHLX, the stock's 10-day put/call volume ratio of 1.00 ranks higher than 70% of all other readings from the past year -- suggesting options traders have been buying to open puts over calls at a faster-than-usual clip lately.

A Schaeffer's exclusive

6 Sectors for Summer

Access your FREE insider report before it's too late!


  
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Research Exposes Shortcut to Stock Market Wins
A simple way to stop picking losers, and start cashing in like Wall Street's elite.
Google Postpones Android Reveal, "Now is Not the Time to Celebrate"
"Now is not the time to celebrate," Google said in a message on its website
ZNGA Zooms to 8-Year High on Billion-Dollar Deal
ZNGA is planning to buy Peak for $1.8 billion
Huge New Legal Marijuana Market Has Shortage Crisis
250 million Europeans have access to medical marijuana. There's already a shortage....